11 April 2024 Editors Choice 8 Min Read
Another hangover for Remgro
The investment house has been hammered by overpaying for Heineken Beverages and Mediclinic. After 65 years of reliable performance, is it now at risk of enduring a lost decade? And is it time for chair Johann Rupert to shake things up?
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In